Piper Sandler Maintains Overweight on Repare Therapeutics, Lowers Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Joseph Catanzaro maintains an Overweight rating on Repare Therapeutics (NASDAQ:RPTX) but lowers the price target from $30 to $25.
October 16, 2023 | 5:37 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Piper Sandler has maintained an Overweight rating on Repare Therapeutics but lowered the price target from $30 to $25.
The news is directly related to Repare Therapeutics. While the Overweight rating is maintained, indicating a positive outlook, the lowering of the price target could indicate a potential downside, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100